Recce Pharmaceuticals Ltd (RCE) — Cash Flow-to-Debt Ratio
Recce Pharmaceuticals Ltd (RCE) has a Cash Flow-to-Debt Ratio of -0.50x as of December 2025, meaning its operating cash flow of AU$-10.23 Million could theoretically repay 0% of its total liabilities (AU$20.66 Million) in one year. Check Recce Pharmaceuticals Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Recce Pharmaceuticals Ltd Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Recce Pharmaceuticals Ltd across 12 annual periods. Also explore how large is Recce Pharmaceuticals Ltd's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Recce Pharmaceuticals Ltd (2014–2025)
Year-by-year debt coverage analysis for Recce Pharmaceuticals Ltd. For market capitalisation and broader financial context, see RCE company net worth.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.32x | AU$-20.44 Million | AU$15.47 Million | ▼ -61.5% |
| 2024 | -0.82x | AU$-13.01 Million | AU$15.89 Million | ▲ +66.8% |
| 2023 | -2.47x | AU$-12.69 Million | AU$5.14 Million | ▲ +29.9% |
| 2022 | -3.52x | AU$-9.01 Million | AU$2.56 Million | ▲ +47.3% |
| 2021 | -6.67x | AU$-7.86 Million | AU$1.18 Million | ▼ -63.2% |
| 2020 | -4.09x | AU$-3.81 Million | AU$931.53K | ▼ -107.8% |
| 2019 | -1.97x | AU$-2.61 Million | AU$1.33 Million | ▲ +49.0% |
| 2018 | -3.86x | AU$-1.73 Million | AU$448.82K | ▼ -35.1% |
| 2017 | -2.86x | AU$-2.50 Million | AU$874.44K | ▲ +63.3% |
| 2016 | -7.77x | AU$-1.61 Million | AU$206.80K | ▼ -615.3% |
| 2015 | -1.09x | AU$-296.14K | AU$272.47K | ▼ -2038.1% |
| 2014 | 0.06x | AU$11.43K | AU$203.81K | — |